Indo Us Bio-Tech Limited Issues Clarification on Recent Stock Price Movement
Indo Us Bio-Tech Limited issued a clarification on March 11, 2026, regarding significant stock price movement observed on March 10, 2026. The company stated it has no undisclosed material information that could affect share price and attributed the movement to market-driven investor sentiment. The management confirmed compliance with SEBI disclosure requirements and emphasized that all price-sensitive information has been promptly disclosed.
*this image is generated using AI for illustrative purposes only.
Indo Us Bio-Tech Limited has issued a formal clarification to stock exchanges regarding recent significant movement in its share price. The company responded to inquiries from BSE and NSE dated March 10, 2026, addressing concerns about unusual price and volume behavior in its scrip.
Company's Official Response
In its clarification dated March 11, 2026, Indo Us Bio-Tech Limited stated that it is not aware of any information or announcement, including any impending announcement, which could have a bearing on the price or volume behavior of its shares. The company emphasized its commitment to transparency and regulatory compliance.
| Parameter | Details |
|---|---|
| Response Date | March 11, 2026 |
| Inquiry Date | March 10, 2026 |
| BSE Scrip Code | 541304 |
| NSE Symbol | INDOUS |
| Signatory | Ms. Dimpy Joshi, Company Secretary |
Regulatory Compliance Statement
The company assured that it has been making prompt disclosures of all events and information that have a bearing on its operations or performance. This includes all price-sensitive information as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The management confirmed that no material information has been withheld that could influence the stock's price movement.
Market-Driven Movement
According to the company's assessment, the movement in share price appears to be purely market-driven and attributed to investor sentiment rather than any fundamental corporate developments. This clarification aims to address market speculation and provide transparency to investors and stakeholders.
Investor Information Access
The company highlighted that all disclosures are made available on its official website at indousagriseeds.com for easy access by investors, ensuring compliance with SEBI LODR Regulations. This practice demonstrates the company's commitment to maintaining transparency and providing timely information to its stakeholder community.
The clarification was digitally signed by Ms. Dimpy Joshi, Company Secretary and Compliance Officer, reinforcing the company's adherence to corporate governance standards and regulatory requirements.
Historical Stock Returns for Indo Us Bio-Tech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.44% | -28.24% | -22.37% | -31.88% | -43.92% | -65.49% |
15
